跳至主要内容
临床试验/ACTRN12610000635066
ACTRN12610000635066已完成2 期

Efficacy Of N-Acetyl Cysteine on Social Skills, Communication and Behaviour In Autistic Children: A Double-Blind, Placebo-Controlled Randomised Trial

niversity of Melbourne0 个研究点目标入组 80 人开始时间: 2010年8月3日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
3 Years 至 10 Years(—)
性别
All

入选标准

  • Meet Diagnostic and Statistical Manual, Fourth Edition, Text Revision (DSM-IV-TR) criteria for Autistic Disorder. If on pharmacological therapies, participants must be on stable therapy for 2 weeks prior to commencing the trial

排除标准

  • Individuals with a primary diagnosis of Asperger’s Disorder, or other Pervasive Developmental Disorders. Children with a known or suspected clinically relevant systemic medical disorder. Children who have had a prior sensitivity or allergy to N-acetyl cysteine (NAC) or gluten (corn starch). Inability to comply with the treatment protocol, for example fussy restricted diet that may lead to refusal to take NAC. Parental non-fluency in English. History of epilepsy. Clinically relevant biochemical or haematological abnormalities at baseline.

研究者

发起方
niversity of Melbourne

相似试验